Skip to main content

Peer Review reports

From: Health economics study of paliperidone palmitate in the treatment of schizophrenia: a 12-month cohort study

Original Submission
29 Dec 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Feb 2024 Reviewed Reviewer Report
7 Mar 2024 Reviewed Reviewer Report
9 Apr 2024 Author responded Author comments - Jicai Wang
Resubmission - Version 3
9 Apr 2024 Submitted Manuscript version 3
12 Apr 2024 Author responded Author comments - Jicai Wang
Resubmission - Version 4
12 Apr 2024 Submitted Manuscript version 4
13 Apr 2024 Author responded Author comments - Jicai Wang
Resubmission - Version 5
13 Apr 2024 Submitted Manuscript version 5
15 Apr 2024 Author responded Author comments - Jicai Wang
Resubmission - Version 6
15 Apr 2024 Submitted Manuscript version 6
16 Apr 2024 Reviewed Reviewer Report
26 Apr 2024 Reviewed Reviewer Report
20 May 2024 Author responded Author comments - Jicai Wang
Resubmission - Version 7
20 May 2024 Submitted Manuscript version 7
Publishing
29 May 2024 Editorially accepted
12 Jun 2024 Article published 10.1186/s12888-024-05874-1

You can find further information about peer review here.

Back to article page